Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)
82.01
+4.68 (6.05%)
Apr 29, 2025, 2:45 PM CST
SHE:002821 Revenue
Asymchem Laboratories (Tianjin) had revenue of 1.54B CNY in the quarter ending March 31, 2025, with 10.10% growth. This brings the company's revenue in the last twelve months to 5.95B, down -14.76% year-over-year. In the year 2024, Asymchem Laboratories (Tianjin) had annual revenue of 5.80B, down -25.82%.
Revenue (ttm)
5.95B
Revenue Growth
-14.76%
P/S Ratio
4.49
Revenue / Employee
619.70K
Employees
9,595
Market Cap
26.70B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.80B | -2.02B | -25.82% |
Dec 31, 2023 | 7.83B | -2.43B | -23.70% |
Jan 1, 2023 | 10.26B | 5.62B | 121.40% |
Dec 31, 2021 | 4.63B | 1.50B | 47.67% |
Dec 31, 2020 | 3.14B | 676.74M | 27.51% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |